🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study seeks to understand the performance of MRI to characterize pancr...
Status
Enrolling By Invitation
Location
Cincinnati Children's Hospital Medical Center
Start Date
2023-01-18
Trial ID
NCT05659147
Vitamin D(Vit D) is a pro-differentiation agent that enhances the accumulat...
Status
Completed
Location
Dong-A University
Start Date
2014-05
Trial ID
NCT02976727
This Phase IV study is an a multi-centre, randomised open label, two way cr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-14
Trial ID
NCT02233803
The purpose of this study is to test see the combined effects of the study ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2017-01-23
Trial ID
NCT03033303
Treatments Being Tested
GSK159802 is a potent, inhaled, long acting selective beta-2-receptor agoni...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-08-24
Trial ID
NCT00364273
Treatments Being Tested
This research study is evaluating the safety and efficacy of a combination ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2020-07-20
Trial ID
NCT04290546
Treatments Being Tested
This study is the first administration of GSK610677 to man. The main aim of...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-05-26
Trial ID
NCT00694902
This is a treatment guideline to allow routine clinical data to be collecte...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-01
Trial ID
NCT01685411
The primary objective is to document the safety of tecemotide (L-BLP25) pha...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00157196
Treatments Being Tested
The goal of this clinical research study is to find the highest safe dose o...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2005-08
Trial ID
NCT00147225
Treatments Being Tested